title: The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD.
authors.affiliation: Molecular Imaging Program for Mood and Anxiety Disorders, New York University Langone Medical Center, USA. alexander.neumeister@nyumc.org
authors.forename: Alexander
authors.initials: A
authors.lastname: Neumeister
mesh_terms: D055808:Drug Discovery; D063388:Endocannabinoids / Q000494:pharmacology* / Q000627:therapeutic use; D005108:Extinction, Psychological / Q000187:drug effects*; D006801:Humans; D008568:Memory / Q000187:drug effects / Q000502:physiology*; D043882:Receptors, Cannabinoid / Q000187:drug effects*; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy* / Q000503:physiopathology; D013315:Stress, Psychological / Q000503:physiopathology
chemical_list: D063388:Endocannabinoids; D043882:Receptors, Cannabinoid